US Oncology(USON) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : US Oncology(USON)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Bryce Elkins who wrote (34)	1/2/2000 1:11:00 PM
From: Gary Korn	Read Replies (2) of 75

Today's Individual Investor has USON highlighted on its insider buying tracker: individualinvestor.com US Oncology Inc. (NASDAQ: USON - Quotes, News, Boards) $4.53 This national physician practice management focusing exclusively on oncology trades at 0.4 times sales and 10 times earnings. Insiders think that the stock is undervalued. In November executives bought over 1.1 million shares at an average price of $4.60 -or about 23% off the 52-week low. The US oncology sector is widely expected to recover. Wall Street expects the company to earn $0.64 per share in current fiscal 1999 and $0.69 per share in the next 2000.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next